Opioids overprescribed to patients taking certain sedatives
(Reuters Health) – Narcotic painkillers can be particularly dangerous for patients who also take tranquilizing drugs known as benzodiazepines, but…
Global leaders seek to reignite fight against deadly malaria
LONDON, April 18 (Reuters) – Renewed action and boosted funding to fight malaria could prevent 350 million cases of the…
FDA approves Ultragenyx’s drug for rare form of rickets
(Reuters) – The U.S. Food and Drug Administration has approved Ultragenyx Pharmaceutical Inc’s treatment for a rare and inherited form…
J&J Baby Powder litigation takes new focus with asbestos claims
NEW YORK (Reuters) – A $117 million verdict against Johnson & Johnson (JNJ.N) and a supplier in favor of a…
Biotech M&A rolls on as Alex ion snaps up Wilson for $855 mln
(Reuters) – Alex ion Pharmaceuticals has agreed to buy Sweden’s Wilson Therapeutics for 7.1 billion Swedish crowns ($855 million), boosting…
Theranos lays off most of its remaining workforce: WSJ
(Reuters) – Embattled blood-testing company Theranos Inc laid off most of its remaining workforce to preserve cash and avert or…
Merck’s Keytruda helps lung cancer patients live longer in trial
(Reuters) – Merck & Co’s (MRK.N) blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in a late-stage…
Medical studies in humans often launched on faulty evidence base
(Reuters Health) – New research reveals serious flaws in the animal studies that regulators and ethicists use to decide if…
Lilly’s Cyramza succeeds in late-stage liver cancer trial
(Reuters) – Eli Lilly and Co on Wednesday said its drug Cyramza met the main goal of helping patients live…
Pfizer signs deal with Allogene to develop cancer cell therapy
(Reuters) – Pfizer Inc said on Tuesday it signed an agreement with Allogene Therapeutics, a company formed by a consortium…
FDA refuses to review Alkermes’ depression treatment, seeks more trials
(Reuters) – Alkermes Plc has been told to conduct more clinical trials of its experimental depression treatment after the U.S.…
Arkansas sues opioid manufacturers for roles in epidemic
(Reuters) – Arkansas’ attorney general on Thursday joined the widening mass of litigation against opioid manufacturers, accusing three drugmakers of…
People with sinus infections stay on antibiotics too long
(Reuters Health) – Most people prescribed antibiotics for sinus infections are on treatment courses of 10 days or longer even…
Impax reaches $20 million deal to end trial over generic drug’s delay
BOSTON (Reuters) – Impax Laboratories Inc has agreed to pay $20 million to consumers and insurers to resolve claims that…
Esperion’s drug clears study as add-on cholesterol treatment
(Reuters) – Esperion Therapeutics Inc said on Tuesday its experimental oral drug met the main goal of reducing cholesterol by…
Biohaven plunges as investors pit migraine data against Allergan’s drug
(Reuters) – Biohaven Pharmaceutical Holding said its treatment for acute migraine cleared two late-stage studies, but investors worried about its…
AbbVie’s lung cancer drug data disappoints; shares slump
(Reuters) – AbbVie Inc’s experimental lung cancer drug data was not effective enough to seek a faster approval, in a…
U.S. judge says opioid settlement roadblocks may prompt trials
(Reuters) – A federal judge pushing for a settlement in lawsuits by state and local governments against drug companies over…
FDA panel backs Pfizer’s Xeljanz as bowel disease treatment
(Reuters) – Pfizer Inc’s Xeljanz should be approved to treat patients with moderate to severe ulcerative colitis, a chronic bowel…